跳至主要内容
临床试验/NCT06338280
NCT06338280招募中2 期

Remote Observed Methadone Evaluation Phase II (ROME II): Retention and Costs of Care

Sonara Health2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2024年12月24日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
100
试验地点
2
主要终点
Retention

研究概览

简要总结

Methadone is an effective treatment for severe opioid use disorder (OUD), but access is limited due to the requirement of daily observed dosing by most opioid treatment programs (OTPs). Sonara Health designed a HIPAA-compliant web-application called Sonara that features integrated video dosing recording, a tamper-evident seal, and an innovative measurement-based care (MBC) framework called the Opioid Craving Visual Analogue Scale (OC-VAS) to facilitate methadone take-homes while providing evidence of appropriate use and monitoring patient outcomes. Phase II of this SBIR aims to compare Sonara against usual take-homes to assess its impact on retention in care, opioid use, patient outcomes, and costs of care.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 64 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Willing to participate in a randomized trial
  • Able to complete study instruments and interviews

排除标准

  • Less than 18 years of age
  • Pregnant or planning to be pregnant
  • Currently involved in the criminal justice system
  • Serious mental health problems
  • Treated with buprenorphine
  • Please note: The enrollment target (2.5 randomizations per week over 50 weeks) includes oversampling women and under-represented racial/ethnicity groups (i.e., at least 10 or more individuals per group who identify as Black, Hispanic, and American Indian/Alaskan Native).

结局指标

主要结局

Retention

时间窗: 24 weeks

Length of time the patient remains in treatment after study enrollment

Take homes received over time

时间窗: 24 weeks

The number of take home doses of methadone received at 4-, 12-, and 24-weeks following randomization

次要结局

  • Urine toxicology(24 weeks)
  • Opioid cravings(24 weeks)
  • Health-related quality of life(24 weeks)
  • Opioid withdrawal severity(24 weeks)
  • Drug Abuse Treatment Costs Analysis(24 weeks)

研究者

发起方
Sonara Health
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验